Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Margaret Macro"'
Autor:
Joseph R. Mace, Mourad Tiab, Philippe Moreau, Torben Plesner, Margaret Macro, Aurore Perrot, Katja Weisel, Noopur Raje, Michael O'Dwyer, Maia Trial Investigators, Shaji Kumar, Tahamtan Ahmadi, Clarissa M. Uhlar, Michel Attal, Ming Qi, Hang Quach, Thierry Facon, Hartmut Goldschmidt, Cyrille Hulin, Jianping Wang, Laurent Frenzel, Hareth Nahi, Robert Z. Orlowski, Rachel Kobos, Nizar J. Bahlis, Christopher P. Venner, Rian Van Rampelbergh, Christopher Chiu, Xavier Leleu, Supratik Basu, Saad Z. Usmani
Publikováno v:
Facon, T, Kumar, S, Plesner, T, Orlowski, R Z, Moreau, P, Bahlis, N, Basu, S, Nahi, H, Hulin, C, Quach, H, Goldschmidt, H, O’Dwyer, M, Perrot, A, Venner, C P, Weisel, K, Mace, J R, Raje, N, Attal, M, Tiab, M, Macro, M, Frenzel, L, Leleu, X, Ahmadi, T, Chiu, C, Wang, J, Rampelbergh, R V, Uhlar, C M, Kobos, R, Qi, M, Usmani, S Z, MAIA Trial Investigators & Abildgaard, N 2019, ' Daratumumab plus lenalidomide and dexamethasone for untreated Myeloma ', New England Journal of Medicine, vol. 380, no. 22, pp. 2104-2115 . https://doi.org/10.1056/NEJMoa1817249
BACKGROUND: Lenalidomide plus dexamethasone is a standard treatment for patients with newly diagnosed multiple myeloma who are ineligible for autologous stem-cell transplantation. We sought to determine whether the addition of daratumumab would signi
Autor:
Michael Uppenkamp, Vít Procházka, Catherine Thieblemont, R. Bouabdallah, Wolfgang Hiddemann, Michael Pfreundschuh, M. Andre, Marek Trneny, Michael Hallek, Martin Dreyling, Josée M. Zijlstra, Jan Walewski, Roswitha Forstpointner, Eva Hoster, Stephan Kremers, Christian H. Geisler, Vincent Ribrag, Stephan Stilgenbauer, Gérard Lepeu, Bertrand Coiffier, Laurence Sanhes, Wolfram Klapper, Ursula Vehling-Kaiser, Margaret Macro, P. Feugier, H. Tilly, Michael Unterhalt, P. J. Lugtenburg, Michal Szymczyk, Olivier Hermine, Hanneke C. Kluin-Nelemans, F. Di Raimondo, Lothar Kanz, J.K. Doorduijn
Publikováno v:
New England Journal of Medicine, 367(6), 520-531. Massachussetts Medical Society
Kluin-Nelemans, H C, Hoster, E, Hermine, O, Walewski, J, Trneny, M, Geisler, C H, Stilgenbauer, S, Thieblemont, C, Vehling-Kaiser, U, Doorduijn, J K, Coiffier, B, Forstpointner, R, Tilly, H, Kanz, L, Feugier, P, Szymczyk, M, Hallek, M, Kremers, S, Lepeu, G, Sanhes, L, Zijlstra-Baalbergen, J M, Bouabdallah, R, Lugtenburg, P J, Macro, M, Pfreundschuh, M, Prochazka, V, Di Raimondo, F, Ribrag, V, Uppenkamp, M, Andre, M, Klapper, W, Hiddemann, W, Unterhalt, M & Dreyling, M H 2012, ' Treatment of Older Patients with Mantle-Cell Lymphoma ', New England Journal of Medicine, vol. 367, no. 6, pp. 520-531 . https://doi.org/10.1056/NEJMoa1200920
New England Journal of Medicine, 367(6), 520-531. MASSACHUSETTS MEDICAL SOC
Kluin-Nelemans, H C, Hoster, E, Hermine, O, Walewski, J, Trneny, M, Geisler, C H, Stilgenbauer, S, Thieblemont, C, Vehling-Kaiser, U, Doorduijn, J K, Coiffier, B, Forstpointner, R, Tilly, H, Kanz, L, Feugier, P, Szymczyk, M, Hallek, M, Kremers, S, Lepeu, G, Sanhes, L, Zijlstra-Baalbergen, J M, Bouabdallah, R, Lugtenburg, P J, Macro, M, Pfreundschuh, M, Prochazka, V, Di Raimondo, F, Ribrag, V, Uppenkamp, M, Andre, M, Klapper, W, Hiddemann, W, Unterhalt, M & Dreyling, M H 2012, ' Treatment of Older Patients with Mantle-Cell Lymphoma ', New England Journal of Medicine, vol. 367, no. 6, pp. 520-531 . https://doi.org/10.1056/NEJMoa1200920
New England Journal of Medicine, 367(6), 520-531. MASSACHUSETTS MEDICAL SOC
BACKGROUNDThe long-term prognosis for older patients with mantle-cell lymphoma is poor. Chemoimmunotherapy results in low rates of complete remission, and most patients have a relapse. We investigated whether a fludarabine-containing induction regime